This article details the recent warning letters sent by the FDA to CBD companies marketing products for animals, citing safety concerns due to their use of unproven therapeutic claims. While this is not new news, it does reiterate the fact that the FDA considers any product that is marketed using medical or therapeutic claims as a “drug,” and there are no approved CBD drugs for animals.
This is especially impactful for food-producing animals, because withdrawal times have yet to be established, and these timelines are necessary for preventing unwanted substances from entering the human food supply.
In the CBD for Pets industry, these recent letters serve as yet another reminder that the FDA needs to provide a clear, regulatory pathway for CBD companies to lawfully market and provide their products to the public.
Click below to read the article: https://hemptoday.net/fda-crackdown-on-cbd-extends-to-makers-of-products-for-animals/